Oncoustics

Oncoustics is a unique and innovative player in the medical AI space today. Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. We apply AI to raw ultrasound signals from readily available handheld ultrasound devices to rapidly differentiate healthy versus diseased tissues. Initially we are targeting liver disease, a $30B global diagnostic market.

This year we’re filing our FDA 510(k) for Onc 001 that detects liver fibrosis. Several follow-on liver products are in development. We also have clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers.